Cocrystal Pharma Inc

NASDAQ:COCP  
1.86
+0.15 (+8.77%)
4:38:02 PM EDT: $1.99 +0.13 (+6.99%)
Earnings Announcements

Cocrystal Pharma Posts Quarterly Net Loss $2.7 Million

Published: 11/16/2020 13:49 GMT
Cocrystal Pharma Inc (COCP) - Cocrystal Pharma Reports Third Quarter 2020 Financial Results and Provides Update on Antiviral Programs.
Cocrystal Pharma Inc Qtrly Net Loss $2.7 Million Compared With a Net Loss of $1.8 Million.
Revenue is expected to be $0.58 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0.6 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.